The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA) in patients with Duchenne muscular ...
Ad hoc announcement pursuant to Art. 53 LR FORTITUDE study met primary and key secondary endpoints of reduction in KHDC1L and ...
A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver ...
Learn more Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at ...
Your muscles need continuous maintenance to stay strong and healthy. Duchenne muscular dystrophy (DMD) happens when there is a change in a person's genetic instructions that affects the production of ...
Health Canada Priority Review targets an expedited 180-day review period for givinostat, reflecting Italfarmaco’s commitment to Canadian DMD ...
June 11 (Reuters) - Novartis said on Thursday an experimental drug, which it acquired as part of its $12 billion takeover of ...
– Significant decreases in levels of serum creatine kinase (CK) and fast skeletal muscle troponin I (TNNI2), enzyme biomarkers associated with skeletal muscle damage– BOULDER, Colo.--(BUSINESS ...
Engineered extracellular vesicles delivering full-length DMD mRNA restored dystrophin and improved muscle strength and ...
Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an ...
Atlantic at Acadia University, representatives from Muscular Dystrophy Canada's Nova Scotia branch were on hand fu ...
15-year-old Santi's current chair no longer fits him properly and is not safe for daily use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results